#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Chronic granulomatous disease Thalassaemia beta Factor IX deficiency Vulval cancer recurrent Soft tissue sarcoma Andersen-Tawil syndrome Short stature Medulloblastoma recurrent Pulmonary fibrosis Mitochondrial encephalomyopathy Leukocyte adhesion deficiency Tourette's disorder Chordoma Rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Vascular malformation – Basic Information Haemophilia B with anti factor IX – Trials in Disease Ehlers-Danlos syndrome – Diagnostics Hepatic angiosarcoma – Treatment Haemophilia A with anti factor VIII – Trials in Disease Mucopolysaccharidosis II – Treatment Hypereosinophilic syndrome X-linked lymphoproliferative syndrome – Basic Information Pulmonary fibrosis – Treatment Progressive multifocal leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Edoxaban Povidone Sodium Chloride Ph. Eur. Ion440 Hydroxychloroquine Sulfate Gad20-209-Fsp-A1 Taxanes Esmolol Hydrochloride Mbs2320 Migalastat Ciclosporin HUMAN THROMBIN Thiamine Hydrochloride Cariprazine Hydrochloride Selexipag Fostemsavir Trometamol Toldc Doxazosin Mesilate Lisdexamfetamine Dimesylate Nimodipine More therapies…

    Learn about Your Condition

    Ventricular tachycardia Cachexia Small intestine leiomyosarcoma Peptostreptococcus infection Chronic sinusitis ROHHAD syndrome Round cell liposarcoma Death neonatal Depression Electrocorticogram Post-acute COVID-19 syndrome Pulmonary sarcoidosis Erythema Neuralgia Fibrous dysplasia of bone More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness of Dermatophagoides Allergen Extracts for Allergy Patients Using Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Solutions

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus
    • Histamine Dihydrochloride
    • Sodium Chloride
    Spain

  • Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Cannabidiol
    France

  • Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    • Docetaxel
    Finland Greece Hungary Iceland Italy Portugal +3

  • Study of Oxytocin Nasal Spray as Add-on Treatment for Children with Autism Spectrum Disorder and Intellectual Disability: Safety and Feasibility Assessment

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Oxytocin
    • Sodium Chloride
    France

  • Study on the Effects of Adalimumab, Vedolizumab, and Tofacitinib on Heart Health in Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Tofacitinib
    • Adalimumab
    • Golimumab
    France

  • Study on the Safety of Sirolimus for Children with Familial Adenomatous Polyposis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Sirolimus
    France
Previous Page
1 … 854 855 856 857 858 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!